Academic Bibliography

Search 200 years of publications by Ghent University researchers.

prof. dr. Karim Vermaelen

Work address: C. Heymanslaan 10, ingang 12 - verdieping 6
9000 Gent
Email: Karim.Vermaelen@UGent.be
ORCID iD: 0000-0002-6787-8577

Show Sort by

Add to list
- Journal Article
Treatment of a patient with severe cytomegalovirus (CMV) infection after haploidentical stem cell transplantation with donor-derived CMV-specific T cells

Joline Ingels (UGent) , Saskia De Smet, Kelly Heyns, Nele Lootens, Jonas Segaert, Tom Taghon (UGent) , Georges Leclercq (UGent) , Karim Vermaelen (UGent) , Evelyne Willems, Etienne Baudoux, et al.

(2020) Acta Clinica Belgica. p.1-5
Add to list
- Journal Article
Shallow whole-genome sequencing of plasma cell-free DNA accurately differentiates small from non-small cell lung carcinoma

Lennart Raman (UGent) , Malaïka Van Der Linden (UGent) , Kim Van der Eecken (UGent) , Karim Vermaelen (UGent) , Ingel Demedts, Veerle Surmont (UGent) , Ulrike Himpe, Franceska Dedeurwaerdere, Liesbeth Ferdinande (UGent) , Yolande Lievens (UGent) , et al.

(2020) Genome Medicine.
Add to list
To treat or not to treat? Managing comorbidities in cancer patients under immune checkpoint inhibition

Stijn De Keukeleire (UGent) , Tijl Vermassen (UGent) , Gert De Schoenmakere, Vibeke Kruse (UGent) , Karim Vermaelen (UGent) and Sylvie Rottey (UGent)

(2019) ACTA CLINICA BELGICA.
Add to list
- Journal Article
- A1
- open access
Vaccine strategies to improve anti-cancer cellular immune responses

Karim Vermaelen (UGent)

(2019) FRONTIERS IN IMMUNOLOGY. 10.
Add to list
- Journal Article
- A1
- open access
Invasive aspergillosis mimicking metastatic lung cancer

Michiel Vanfleteren (UGent) , Anne-Marie C Dingemans, Veerle Surmont (UGent) , Karim Vermaelen (UGent) , Alida A Postma, Astrid ML Oude lashof, Cordula CM Pitz and Lizza EL Hendriks

(2018) FRONTIERS IN ONCOLOGY. 8.
Add to list
An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA loaded dendritic cells for cancer vaccination

Elisabeth Brabants (UGent) , Kelly Heyns (UGent) , S De Smet, Pam Devreker (UGent) , Joline Ingels (UGent) , Nancy De Cabooter (UGent) , Veronique Debacker (UGent) , Melissa Dullaers (UGent) , JP Van Meerbeeck, Bart Vandekerckhove (UGent) , et al.

(2018) CYTOTHERAPY. 20(9). p.1164-1181
Add to list
Immunoengineering through cancer vaccines - A personalized and multi-step vaccine approach towards precise cancer immunity

Lien Lybaert (UGent) , Karim Vermaelen (UGent) , Bruno De Geest (UGent) and Lutz Nuhn

(2018) JOURNAL OF CONTROLLED RELEASE. 289. p.125-145
Add to list
Perspectives on the integration of immuno-oncology biomarkers and drugs in a health care setting

Karim Vermaelen (UGent) , A Waeytens, O Kholmanskikh, M Van den Bulcke and E Van Valckenborgh

(2018) SEMINARS IN CANCER BIOLOGY. 52. p.166-177
Add to list
- Journal Article
- A2
- open access
An unusual presentation of a case of human psittacosis

Yannick Vande Weygaerde (UGent) , Charlot Versteele (UGent) , Elke Thijs (UGent) , Anton De Spiegeleer (UGent) , Jerina Boelens (UGent) , Daisy Vanrompay (UGent) , Eva Van Braeckel (UGent) and Karim Vermaelen (UGent)

(2018) RESPIRATORY MEDICINE CASE REPORTS. 23. p.138-142
Add to list
- Conference Paper
The immunophenotypical fingerprint of patients with primary antibody deficiencies is partially present in their asymptomatic first-degree relatives.

Delfien Bogaert (UGent) , Marieke De Bruyne (UGent) , Veronique Debacker (UGent) , Pauline Depuydt (UGent) , Katleen De Preter (UGent) , Carolien Bonroy (UGent) , Jan Philippé (UGent) , Maria Bordon Cueto De Braem (UGent) , Bart Lambrecht (UGent) , Tessa Kerre (UGent) , et al.

(2017)

1
2
3
4
…
7
8

Next →